Menu

Clinical neuropsychology/cognitive remediation

Many mental illnesses are known to also be associated with cognitive dysfunction. In the case of disorders such as psychosis, depression and ADHD, it has been shown that extensive diagnosis and subsequent individual treatment of these dysfunctions can contribute to an improvement of the disease.

Cognitive remediation can be divided into a diagnostic area and 3 subsequent therapeutic levels:

Neuropsychological diagnostics

First, a detailed neuropsychological diagnosis is carried out. Various cognitive functional areas, such as attention, memory, speech functions or planning capacity, are examined. The aim is to create individual functional profiles in order to put together a therapy program adapted for each patient.

Restitutive therapy

Here, targeted exercises are performed in different cognitive functional areas e.g. through cognitive training on the PC or with the help of tasks with paper and pencil, for example, in order to increase attention functions (ability to concentrate). The aim of this measure is to achieve a neural reorganization, i.e. a restoration of impaired function through intensive practice.

Compensatory therapy

This therapy is about teaching strategies so that cognitive functions can improve by using other skills or aids or the environment is better adapted to the needs (e.g. learning and using new cognitive strategies, use of organisational aids in everyday life or break management).

Integrative therapy

Through overarching thinking, the use of the knowledge learned in 2 and 3 is transferred into the everyday situation, e.g. behavioural management programs. Elements from behavioural therapy can also be used here. The aim is to treat psychosocial adaptation and disease management or to be acceptable to social, school or occupational reintegration.
The areas of cognitive rewriting are offered as individual and group therapeutic sessions.  In addition, homework can also be done to consolidate what has been learned.

Staff: Neuropsychological examination

Claudia Hanses (TA)
Gabriele Herrmann

Information gemäß § 6 Medizinprodukte-Betreiberverordnung "Beauftragter für Medizinproduktesicherheit"

Sehr geehrte Damen und Herren,

gemäß § 6 Medizinprodukte-Betreiberverordnung steht Ihnen das Universitätsklinikum Bonn im Zusammenhang mit Meldungen über Risiken von Medizinprodukten, Informationen zu Rückrufen oder Warn- und Sicherheitshinweisen sowie bei der Umsetzung von notwendigen korrektiven Maßnahmen unter folgender E-Mailadresse zur Verfügung:

Diese E-Mailadresse richtet sich vorzugsweise an Kontaktpersonen von Behörden, Herstellern und Vertreibern von Medizinprodukten.

This website is using cookies to provide a good browsing experience.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

This website is using cookies to provide a good browsing experience.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Your cookie preferences have been saved.